Boron neutron capture therapy for malignant gliomas

@article{Diaz2000BoronNC,
  title={Boron neutron capture therapy for malignant gliomas},
  author={A. Diaz and J. Coderre and A. Chanana and R. Ma},
  journal={Annals of Medicine},
  year={2000},
  volume={32},
  pages={81 - 85}
}
Boron neutron capture therapy (BNCT) represents a promising modality for a relatively selective radiation dose delivery to the tumour tissue. Boron-10 nuclei capture slow ‘thermal’ neutrons preferentially and, upon capture, promptly undergo 10B(n,α)7Li reaction. The ionization tracks of energetic and heavy lithium and helium ions resulting from this reaction are only about one cell diameter in length (∼ 14 μm). Because of their high linear energy transfer (LET) these ions have a high relative… Expand
Solutions for clinical implementation of boron neutron capture therapy in Finland
Boron neutron capture therapy (BNCT) is an emerging binary radiotherapy method which utilises epithermal neutrons in conjunction with a boron biodistribution to treat patients with certain malignantExpand
Boron neutron capture therapy using reactor epithermal neutron beams could effectively control in‐transit and lymph node metastases originating from a cutaneous malignant melanoma
Dear Editor, Boron neutron capture therapy (BNCT) using boronophenylalanine (BPA) is a selective radiotherapeutic approach for cancer cells and has achieved good results for treating malignantExpand
Proton magnetic resonance spectroscopy of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex
Boron neutron capture therapy (BNCT) is a radiotherapy that has mainly been used to treat malignant brain tumours, melanomas, and head and neck cancer. In BNCT, the patient receives an intravenousExpand
Boron-Containing Bioactive Molecules: An Approach to Boron Neutron Capture Therapy
Boron Neutron Capture Therapy (BNCT) is a binary therapeutic modality for cancer treatment that involves the irradiation of B-localized tumours with low-energy neutrons, which results in theExpand
Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era
TLDR
Boron neutron capture therapy (BNCT) for common cancers will become available at medical institutes that are equipped with an accelerator-based BNCT system when more patients suffering from refractory cancers will be treated. Expand
Ligand Liposomes and Boron Neutron Capture Therapy
Boron neutron capture therapy (BNCT) has been used both experimentally and clinically for the treatment of gliomas and melanomas, with varying results. However, the therapeutic effects onExpand
Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden
TLDR
A boron neutron capture therapy (BNCT) facility has been constructed at Studsvik, Sweden and, presently, a protocol for BNCT treatment of glioblastoma patients who have not received any therapy other than surgery is involved. Expand
Ligand liposomes and boron neutron capture therapy
TLDR
Boron neutron capture therapy (BNCT) has been used both experimentally and clinically for the treatment of gliomas and melanomas, with varying results, but it is uncertain whether enough boron is taken up by micro-invasive tumor cells. Expand
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden
SummaryA boron neutron capture therapy (BNCT) facility has been constructed at Studsvik, Sweden. It includes two filter/moderator configurations. One of the resulting neutron beams has been optimizedExpand
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
TLDR
Although the efficacy of BNCT in the present protocol seems to be comparable with conventional radiotherapy and the treatment time is shorter, the observed side effects and the requirement of complex infrastructure and higher resources emphasize the need of further phase I and II studies, especially directed to improve the accumulation of (10)B in tumour cells. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit.
  • D. Slatkin
  • Materials Science, Medicine
  • Brain : a journal of neurology
  • 1991
TLDR
A new dosimetric analysis of the 1959-1961 clinical trials of BNCT at Brookhaven National Laboratory yields an acute radiation dose tolerance limit estimate of approximately 10 Gy-Eq to the capillary endothelium of human basal ganglia from BnCT. Expand
Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note.
TLDR
Analysis of patients from the United States who received BNCT treatment in Japan does not support a clinically meaningful improvement in survival attributable to this form of therapy, and the actuarial survival curves for the patients with glioblastoma multiforme and their counterparts who received conventional therapy are virtually superimposable. Expand
Brain Tolerance in Dogs to Boron Neutron Capture Therapy with Borocaptate Sodium (BSH) or Boronophenylalanine (BPA)
Research programs investigating the potential use of BNCT for brain tumors have been initiated in Europe and in the U.S. using epithermal neutron beams and either borocaptate sodium (BSH) orExpand
Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
A number of carborane-containing porphyrins were administered to mice bearing subcutaneously transplanted mammary carcinomas. Administration was via serial intraperitoneal (i.p.) injections to assessExpand
Installation and testing of an optimized epithermal neutron beam at the Brookhaven Medical Research Reactor (BMRR).
TLDR
A perusal of data on parameters obtained in NCT indicates that the TG would increase significantly beyond values projected in this paper if the absolute amount of 10B could be increased above 30 ppm. Expand
The Monte Carlo Simulation of the Biological Effect of the 10B(n,α)7Li Reaction in Cells and Tissue and Its Implication for Boron Neutron Capture Therapy
The energy deposition in the nucleus of cells exposed to the /sup 10/B(n, alpha)/sup 7/Li neutron capture reaction has been calculated and compared to the measured biological effect of this reaction.Expand
Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy.
TLDR
It can be suggested that BNCT is a radiotherapy that can produce "cure" of both malignant and benign brain tumors while preserving a good quality of life if conducted without conventional radiotherapy. Expand
Enhancement of the epithermal neutron beam used for boron neutron capture therapy.
TLDR
The epithermal neutron beam at the Brookhaven Medical Research Reactor has gained a 50% increase in the epitherm neutron flux and the fast neutron and gamma doses per epither mal neutron are reduced slightly after the rearrangement of the fuel elements in the core. Expand
Central nervous system radiation syndrome in mice from preferential 10B(n, alpha)7Li irradiation of brain vasculature.
TLDR
Results are compatible with morphologic evidence that endothelial cell damage is a major determinant of acute lethality from the CNS radiation syndrome and it was observed that boric acid is a low linear energy transfer radiation-enhancement agent in vivo. Expand
Long‐term follow‐up for brain metastases treated by percutaneous stereotactic single high‐dose irradiation
Surgery is considered the treatment of choice for solitary brain lesions, and radiation therapy is indicated for metastases only in vital or sensitive regions that cannot be excised without risk ofExpand
...
1
2
3
...